Health Catalyst (HCAT) Stock Price

Health Catalyst Price

NASDAQ·CLOSED
2.10USD-0.06 (-2.82 %)
Market closed

Revenue has compounded at 19.8% per year over the past 8 years to 311.14 M USD. Health Catalyst's net margin stands at -57.2%, up from -63.3% several years earlier. Analysts set a median price target of 3.95 USD, implying 88.2% above the current price. Of 17 analysts, 8 rate the stock a buy — an overall Hold consensus. Over the past year Health Catalyst shares have lost 48.1%. The stock trades about 111% above its 52-week low.

Health Catalyst stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Health Catalyst over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Health Catalyst stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Health Catalyst's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Health Catalyst Stock Price History
DateHealth Catalyst Price
7/21/20262.10 USD
7/20/20262.16 USD
7/17/20262.25 USD
7/16/20262.28 USD
7/15/20262.33 USD
7/14/20262.29 USD
7/13/20262.27 USD
7/10/20262.29 USD
7/9/20262.24 USD
7/8/20262.13 USD
7/7/20262.27 USD
7/6/20262.12 USD
7/2/20262.08 USD
7/1/20262.07 USD
6/30/20261.99 USD
6/29/20261.96 USD
6/26/20261.90 USD
6/25/20261.77 USD
6/24/20261.72 USD
6/23/20261.76 USD
6/22/20261.64 USD
6/18/20261.74 USD
6/17/20261.77 USD
6/16/20261.78 USD
6/15/20261.84 USD
6/12/20261.85 USD
6/11/20261.64 USD
6/10/20261.60 USD
6/9/20261.71 USD
6/8/20261.75 USD
6/5/20261.93 USD
6/4/20261.94 USD
6/3/20261.33 USD
6/2/20261.35 USD
6/1/20261.39 USD
5/29/20261.38 USD
5/28/20261.40 USD
5/27/20261.30 USD
5/26/20261.26 USD
5/22/20261.29 USD
5/21/20261.29 USD
5/20/20261.29 USD
5/19/20261.27 USD
5/18/20261.27 USD
5/15/20261.19 USD
5/14/20261.17 USD
5/13/20261.34 USD
5/12/20261.48 USD
5/11/20261.38 USD
5/8/20261.52 USD
5/7/20261.59 USD
5/6/20261.57 USD
5/5/20261.60 USD
5/4/20261.57 USD
5/1/20261.45 USD
4/30/20261.25 USD
4/29/20261.27 USD
4/28/20261.34 USD
4/27/20261.37 USD
4/24/20261.38 USD
4/22/20261.31 USD
4/21/20261.32 USD
4/20/20261.26 USD
4/17/20261.32 USD
4/16/20261.27 USD
4/15/20261.23 USD
4/14/20261.12 USD
4/13/20261.06 USD
4/10/20261.00 USD
4/9/20261.01 USD
4/8/20261.03 USD
4/7/20261.10 USD
4/6/20261.16 USD
4/2/20261.17 USD
4/1/20261.16 USD
3/31/20261.27 USD
3/30/20261.18 USD
3/27/20261.10 USD
3/26/20261.10 USD
3/25/20261.10 USD
3/24/20261.10 USD
3/23/20261.21 USD
3/20/20261.23 USD
3/19/20261.22 USD
3/18/20261.16 USD
3/17/20261.17 USD
3/16/20261.22 USD
3/13/20261.32 USD
3/12/20261.79 USD
3/11/20261.86 USD
3/10/20261.82 USD
3/9/20261.91 USD
3/6/20261.95 USD
3/5/20261.93 USD
3/4/20261.95 USD
3/3/20261.72 USD
3/2/20261.68 USD
2/27/20261.62 USD
2/26/20261.75 USD
2/25/20261.79 USD
2/24/20261.73 USD
2/23/20261.70 USD
2/20/20261.79 USD
2/19/20261.86 USD
2/18/20261.77 USD
2/17/20261.73 USD
2/13/20261.84 USD
2/12/20261.84 USD
2/11/20261.99 USD
2/10/20262.06 USD
2/9/20262.16 USD
2/6/20262.15 USD
2/5/20262.09 USD
2/4/20262.17 USD
2/3/20262.18 USD
2/2/20262.30 USD
1/30/20262.15 USD
1/29/20262.16 USD
1/28/20262.19 USD
1/27/20262.22 USD
1/26/20262.21 USD
1/23/20262.25 USD
1/22/20262.36 USD
1/21/20262.30 USD
1/20/20262.21 USD
1/16/20262.31 USD
1/15/20262.34 USD
1/14/20262.31 USD
1/13/20262.40 USD
1/12/20262.46 USD
1/9/20262.47 USD
1/8/20262.45 USD
1/7/20262.50 USD
1/6/20262.38 USD
1/5/20262.29 USD
1/2/20262.28 USD
12/31/20252.39 USD
12/30/20252.38 USD
12/29/20252.52 USD
12/26/20252.42 USD
12/24/20252.38 USD
12/23/20252.35 USD
12/22/20252.44 USD
12/19/20252.35 USD
12/18/20252.37 USD
12/17/20252.39 USD
12/16/20252.44 USD
12/15/20252.35 USD
12/12/20252.46 USD
12/11/20252.56 USD
12/10/20252.64 USD
12/9/20252.61 USD
12/8/20252.64 USD
12/5/20252.60 USD
12/4/20252.69 USD
12/3/20252.72 USD
12/2/20252.76 USD
12/1/20252.91 USD
11/28/20252.99 USD
11/26/20252.92 USD
11/25/20252.77 USD
11/24/20252.51 USD
11/21/20252.36 USD
11/20/20252.03 USD
11/19/20252.11 USD
11/18/20252.17 USD
11/17/20252.24 USD
11/14/20252.27 USD
11/13/20252.35 USD
11/12/20252.46 USD
11/11/20252.69 USD
11/10/20252.85 USD
11/7/20252.83 USD
11/6/20252.96 USD
11/5/20253.05 USD
11/4/20253.03 USD
11/3/20253.14 USD
10/31/20253.23 USD
10/30/20253.28 USD
10/29/20253.34 USD
10/28/20253.38 USD
10/27/20253.46 USD
10/24/20253.24 USD
10/23/20253.06 USD
10/22/20253.16 USD
10/21/20253.18 USD
10/20/20253.12 USD
10/17/20253.05 USD
10/16/20253.09 USD
10/15/20253.06 USD
10/14/20252.90 USD
10/13/20252.71 USD
10/10/20252.65 USD
10/9/20252.78 USD
10/8/20252.85 USD
10/7/20252.85 USD
10/6/20252.96 USD
10/3/20252.96 USD
10/2/20252.80 USD
10/1/20252.81 USD
9/30/20252.85 USD
9/29/20252.92 USD
9/26/20252.80 USD
9/25/20252.81 USD
9/24/20252.86 USD
9/23/20252.85 USD
9/22/20252.95 USD
9/19/20252.89 USD
9/18/20253.02 USD
9/17/20252.81 USD
9/16/20252.88 USD
9/15/20253.01 USD
9/12/20253.13 USD
9/11/20253.24 USD
9/10/20253.26 USD
9/9/20253.40 USD
9/8/20253.38 USD
9/5/20253.38 USD
9/4/20253.30 USD
9/3/20253.24 USD
9/2/20253.40 USD
8/29/20253.39 USD
8/28/20253.65 USD
8/27/20253.69 USD
8/26/20253.50 USD
8/25/20253.34 USD
8/22/20253.28 USD
8/21/20253.06 USD
8/20/20252.92 USD
8/19/20253.00 USD
8/18/20253.00 USD
8/15/20252.92 USD
8/14/20252.93 USD
8/13/20253.22 USD
8/12/20253.00 USD
8/11/20252.70 USD
8/8/20252.83 USD
8/7/20253.69 USD
8/6/20253.82 USD
8/5/20253.82 USD
8/4/20253.63 USD
8/1/20253.52 USD
7/31/20253.65 USD
7/30/20253.68 USD
7/29/20253.92 USD
7/28/20254.09 USD
7/25/20253.88 USD
7/24/20253.85 USD
7/23/20254.05 USD
Access this data via the Eulerpool API
Get Free API Key

Health Catalyst Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
241.90 M USD
-115.80 M USD
-153.20 M USD
Jan 1, 2022
276.20 M USD
-135.10 M USD
-137.40 M USD
Jan 1, 2023
295.94 M USD
-86.96 M USD
-118.15 M USD
Jan 1, 2024
306.58 M USD
-55.45 M USD
-69.50 M USD
Jan 1, 2025
311.14 M USD
-36.10 M USD
-177.97 M USD
Jan 1, 2026 (e)
289.67 M USD
-17.83 M USD
25.50 M USD
Jan 1, 2027 (e)
290.80 M USD
-10.66 M USD
30.78 M USD
Jan 1, 2028 (e)
322.20 M USD
-2.61 M USD
26.38 M USD

Health Catalyst Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 23, 2026, 9:50 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2017201820192020202120222023202420252026e2027e2028e
73.00112.00154.00188.00241.00276.00295.00306.00311.00289.00290.00322.00
–53.4237.5022.0828.1914.526.883.731.63-7.070.3511.03
39.7346.4351.9547.8748.5548.5545.4246.0849.5249.5249.5249.52
29.0052.0080.0090.00117.00134.00134.00141.00154.00143.11143.60159.45
-45.00-60.00-54.00-93.00-115.00-135.00-86.00-55.00-36.00-17.00-10.00-2.00
-61.64-53.57-35.06-49.47-47.72-48.91-29.15-17.97-11.58-5.88-3.45-0.62
-58.00-114.00-240.00-115.00-153.00-137.00-118.00-69.00-177.0025.0030.0026.00
–96.55110.53-52.0833.04-10.46-13.87-41.53156.52-114.1220.00-13.33
35.1035.1018.7039.5047.5053.7056.4260.1969.9069.9069.9069.90
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Health Catalyst generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Health Catalyst retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Health Catalyst's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Health Catalyst has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Health Catalyst's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Health Catalyst stock margins

The Health Catalyst margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Health Catalyst. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Health Catalyst.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
48.70 %
-47.87 %
-63.33 %
Jan 1, 2022
48.59 %
-48.91 %
-49.75 %
Jan 1, 2023
45.56 %
-29.38 %
-39.92 %
Jan 1, 2024
46.25 %
-18.09 %
-22.67 %
Jan 1, 2025
49.70 %
-11.60 %
-57.20 %
Jan 1, 2026 (e)
49.70 %
-6.15 %
8.80 %
Jan 1, 2027 (e)
49.70 %
-3.67 %
10.58 %
Jan 1, 2028 (e)
49.70 %
-0.81 %
8.19 %

Health Catalyst Stock Revenue, EBIT, Earnings per Share

The Health Catalyst earnings per share therefore indicates how much revenue Health Catalyst has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
5.09 USD
-2.44 USD
-3.23 USD
Jan 1, 2022
5.14 USD
-2.52 USD
-2.56 USD
Jan 1, 2023
5.25 USD
-1.54 USD
-2.09 USD
Jan 1, 2024
5.09 USD
-0.92 USD
-1.15 USD
Jan 1, 2025
4.45 USD
-0.52 USD
-2.55 USD
Jan 1, 2026 (e)
4.14 USD
-0.26 USD
0.36 USD
Jan 1, 2027 (e)
4.16 USD
-0.15 USD
0.44 USD
Jan 1, 2028 (e)
4.61 USD
-0.04 USD
0.38 USD

Health Catalyst business model & stock analysis

Health Catalyst Inc is a US-based company specializing in the analysis and management of healthcare data. The company was founded in 2008 by Tom Burton, Steve Barlow, and Dale Sanders in Salt Lake City and has since undergone impressive growth. Health Catalyst's story began with the goal of creating a better healthcare system based on strong data analysis and data-driven decision-making. The founders recognized that the lack of data analysis and consistent data quality in the healthcare industry led to inefficient processes and high costs. The company set out to solve these problems and contribute to better patient care and cost savings. Health Catalyst is divided into several divisions to offer a wide range of solutions for the healthcare industry. These include the areas of data and analytics platform, clinical decision support, population health management, and medical imaging. Health Catalyst's platform offers comprehensive data analysis and process improvements in key areas of business to support high-quality healthcare. In the field of clinical decision support, Health Catalyst provides analysis and tools to make clinical decisions based on data and evidence-based medicine. Health Catalyst's Population Health Management division helps insurers and healthcare providers optimize population health management based on data analysis to achieve better outcomes with reduced costs. In the medical imaging field, Health Catalyst offers solutions to improve workflow integration and quality improvements for medical images and data. Health Catalyst's products include the Analytics platform, a comprehensive platform for managing healthcare data for clinical, financial, and operational decision-making. Health Catalyst's clinical workflow applications support doctors and nurses in making informed decisions and providing optimal care to patients. Health Catalyst's product line for Population Health Management provides tools for risk assessment, population health analysis, and clinical decision support for insurance companies and healthcare providers. Health Catalyst's business model is based on the sale of software products, services, and subscriptions for the use of the healthcare data analytics platform. The company targets a broad customer base, including hospitals, clinics, healthcare providers, insurers, and government agencies. Health Catalyst has become a leading provider of healthcare data analytics and decision support systems. The company has built a global presence by offering solutions to healthcare companies worldwide. Health Catalyst has become a strong innovator in the industry by developing innovative technologies and integrating insights from its extensive data analysis into clinical and operational decisions. Overall, Health Catalyst has a strong vision for the future of healthcare. The company helps overcome the numerous challenges in the healthcare industry by focusing on data analytics and evidence-based decision-making. Health Catalyst's innovative technologies and solutions are expected to contribute to improving healthcare and making it more cost-effective in the coming years.

Health Catalyst SWOT Analysis

Strengths

Health Catalyst Inc. has a strong reputation in the healthcare industry, known for their data analytics solutions and expertise.

The company's software platform offers a comprehensive range of tools and features, providing advanced data-driven insights to healthcare organizations.

Health Catalyst Inc. has a talented and experienced team of data scientists and healthcare professionals, enabling them to develop innovative solutions tailored to meet the specific needs of their clients.

Weaknesses

One weakness of Health Catalyst Inc. is their relatively limited market presence compared to some larger competitors in the industry.

The company may face challenges in terms of scalability, as their solutions require significant infrastructure and resources to implement and maintain.

Health Catalyst Inc. may also struggle to keep up with the rapidly evolving technological landscape and changing healthcare regulations, which could impact the effectiveness of their solutions.

Opportunities

The increasing demand for data-driven healthcare solutions presents a significant opportunity for Health Catalyst Inc. to expand their market share and reach.

The company can leverage their expertise in data analytics to develop new products and services that cater to emerging healthcare trends and challenges.

Health Catalyst Inc. can also explore strategic partnerships and collaborations with other healthcare organizations to further enhance their offerings and broaden their customer base.

Threats

One of the major threats faced by Health Catalyst Inc. is the intense competition in the healthcare data analytics market, with numerous well-established players vying for market dominance.

Changes in healthcare policies and regulations can also pose a threat, as organizations may need to adapt or modify their software solutions to remain compliant.

Additionally, cyber threats and data breaches pose a significant risk to the company and its clients, requiring strong security measures and continuous monitoring.

Health Catalyst Segments

Health Catalyst Revenue by Segment (1/4)

  • 3 Years

  • 5 Years

  • Max

Technology
Revenue
Professional services
Details
Date
Technology
Revenue
Professional services
Jan 1, 2019
83.98 M USD
0.00 USD
70.97 M USD
Jan 1, 2020
110.47 M USD
0.00 USD
78.38 M USD
Jan 1, 2021
147.72 M USD
0.00 USD
94.21 M USD
Jan 1, 2022
176.29 M USD
0.00 USD
99.95 M USD
Jan 1, 2023
187.58 M USD
0.00 USD
108.36 M USD
Jan 1, 2024
0.00 USD
194.85 M USD
111.73 M USD
Jan 1, 2025
208.28 M USD
0.00 USD
102.86 M USD

Health Catalyst Revenue by Segment (2/4)

  • 3 Years

  • 5 Years

  • Max

Recurring technology
One-time technology (i.e., perpetual license)
Details
Date
Recurring technology
One-time technology (i.e., perpetual license)
Jan 1, 2019
83.79 M USD
184,000.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
Jan 1, 2023
187.23 M USD
357,000.00 USD
Jan 1, 2024
194.85 M USD
0.00 USD
Jan 1, 2025
208.28 M USD
0.00 USD

Health Catalyst Revenue by Segment (3/4)

  • 3 Years

  • 5 Years

  • Max

Recurring technology
One-time technology (i.e., perpetual license)
Details
Date
Recurring technology
One-time technology (i.e., perpetual license)
Jan 1, 2019
0.00 USD
0.00 USD
Jan 1, 2020
110.47 M USD
0.00 USD
Jan 1, 2021
147.45 M USD
272,000.00 USD
Jan 1, 2022
175.81 M USD
480,000.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD

Health Catalyst Revenue by Segment (4/4)

  • 3 Years

  • 5 Years

  • Max

Technology
Revenue
Professional services
Details
Date
Technology
Revenue
Professional services
Jan 1, 2019
83.98 M USD
0.00 USD
70.97 M USD
Jan 1, 2020
110.47 M USD
0.00 USD
78.38 M USD
Jan 1, 2021
147.72 M USD
0.00 USD
94.21 M USD
Jan 1, 2022
176.29 M USD
0.00 USD
99.95 M USD
Jan 1, 2023
187.58 M USD
0.00 USD
108.36 M USD
Jan 1, 2024
0.00 USD
194.85 M USD
111.73 M USD
Jan 1, 2025
208.28 M USD
0.00 USD
102.86 M USD

Health Catalyst Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Health Catalyst historical P/E ratio, EBIT multiple, and P/S ratio

Health Catalyst annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Health Catalyst shares outstanding

The number of shares of Health Catalyst was 69.9 M in 2025. This indicates how many shares Health Catalyst is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
47.50 M Stocks
Jan 1, 2022
53.70 M Stocks
Jan 1, 2023
56.42 M Stocks
Jan 1, 2024
60.19 M Stocks
Jan 1, 2025
69.90 M Stocks
Jan 1, 2026 (e)
69.90 M Stocks
Jan 1, 2027 (e)
69.90 M Stocks
Jan 1, 2028 (e)
69.90 M Stocks

Current Health Catalyst forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy47.06 % (8)
Hold52.94 % (9)
Sell0.00 % (0)
12M Price Target
3.95
Last Price
2.04
Currency
USD
12M Return Potential
93.75 %
LTM Return
0 %

Health Catalyst Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/12/20260.03USD70.35 MUSD2026 Q2
8/5/20260.03USD70.35 MUSD2026 Q2
5/12/20260.02USD70.55 MUSD2026 Q1
5/11/20260.02USD70.55 MUSD2026 Q1
5/5/20260.02USD70.55 MUSD2026 Q1
3/12/20260.09USD75.46 MUSD2025 Q4
3/3/20260.09USD75.46 MUSD2025 Q4
2/24/20260.09USD75.46 MUSD2025 Q4
8/7/20250.03USD82.22 MUSD2025 Q2
11/12/20240.10USD77.76 MUSD2024 Q3

EESG©

Eulerpool ESG Scorecard© for the Health Catalyst stock

50/100
11
Environment
82
Social
58
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees40
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees18
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Health Catalyst shareholder structure

% Name
18.47162%
First Light Asset Management, LLC
First Light Asset Management, LLC
6.49181%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
6.14756%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
6.10612%
Whetstone Capital Advisors, LLC
Whetstone Capital Advisors, LLC
5.72571%
CDC Financial, Inc.
CDC Financial, Inc.
5.57639%
Stoney Lonesome HF LP
Stoney Lonesome HF LP
...

Health Catalyst Executives and Management Board

BL

Mr. Benjamin Landry

(43)

General Counsel, Corporate Secretary

Compensation1.57 M USD
LL

Ms. Linda Llewelyn

(58)

Chief People Officer

Compensation1.41 M USD
JA

Mr. Jason Alger

(41)

Chief Financial Officer

Compensation1.29 M USD
JK

Mr. John Kane

(72)

Director

Compensation316,161.00 USD
JL

Ms. Julie Larson-Green

(63)

Independent Director

Compensation233,493.00 USD

Health Catalyst Supply Chain

Health Catalyst Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
2 companies
#Name1M3M6M1Y2YTrend
1
Snowflake A
Supplier
0.85
0.80
0.94
0.41
—
2
Microsoft
Supplier
0.37
0.60
0.91
-0.17
0.11

Frequently asked questions about Health Catalyst

The business model of Health Catalyst Inc is focused on providing data and analytics solutions to healthcare organizations. The company aims to enable these organizations in improving patient outcomes, reducing costs, and enhancing operational efficiency by leveraging their vast amount of healthcare data. Health Catalyst offers a comprehensive suite of products and services, including a data platform, analytics applications, and expertise in areas such as quality measures, population health management, and care coordination. By utilizing advanced data analytics, Health Catalyst assists healthcare organizations in making informed decisions, identifying areas for improvement, and ultimately transforming the way healthcare is delivered.

All fundamentals and in-depth analysis of Health Catalyst

Our stock analysis for Health Catalyst stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Catalyst. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Health Catalyst Stock
Health Catalyst Revenue→
Health Catalyst Stock
Health Catalyst Net Income→
Health Catalyst Stock
Health Catalyst P/E→
Health Catalyst Stock
Health Catalyst P/S→
Health Catalyst Stock
Health Catalyst EBIT→
Health Catalyst Stock
Health Catalyst Dividend→
Health Catalyst Stock
Health Catalyst Directors Dealings→
Health Catalyst Stock
Health Catalyst Stocks→
Health Catalyst Stock
Health Catalyst Market capitalization→
Health Catalyst Stock
Health Catalyst Debt→
Health Catalyst Stock
Health Catalyst Liabilities→
Health Catalyst Stock
Health Catalyst Equity→
Health Catalyst Stock
Health Catalyst AAQS→
Health Catalyst Stock
Health Catalyst Employees→
Health Catalyst Stock
Health Catalyst ROE→
Health Catalyst Stock
Health Catalyst ROA→
Health Catalyst Stock
Health Catalyst ROCE→
Health Catalyst Stock
Health Catalyst News→
Health Catalyst Stock
Health Catalyst Analyst Price Targets→

Health Stocks

Health DiscoveryHealiusHealth&Life CoHealios KKHealthcare Global EnterprisesHCW BiologicsHealthcare TriangleHcmed Innovations CoHealthconnHCA HealthcareHealthequityHC Surgical SpecialistsAll Stocks A–Z →